Franklin Touches 52-Week High: How to Play the Stock Now? — Neutral
BEN Zacks Investment Research — August 13, 2025BEN hits a 52-week high on strong AUM growth, acquisitions and solid capital returns but rising expenses pose risks ahead.
Should You Stay Invested in or Sell Nebius Stock Post Q2 Earnings? — Negative
NBIS Zacks Investment Research — August 13, 2025NBIS posts massive Q2 growth and ups ARR forecast, but faces stiff competition, high spending and scaling risks ahead.
Franco-Nevada: Best-In-Class Gold Royalty Player, Not A Bargain Today — Positive
FNV Seeking Alpha — August 13, 2025Franco-Nevada Corporation posted record Q2 revenue and earnings, driven by historic gold prices, strong portfolio performance, and industry-leading margins. Valuation remains at a significant premium, reflecting market confidence but leaving limited short-term upside. Diversification across gold, PGM, and energy assets provides resilience against single-commodity volatility.
First Solar: A Profitable Solar Stock That Gets More Compelling, Risks Remain — Positive
FSLR Seeking Alpha — August 13, 2025FSLR's risk-reward profile is a lot more compelling upon the clarity from One Big Beautiful Bill, with the 45x tax credits likely to sustain its rich profit margins. This is on top of the strategic monetization from the tax credit transfers, allowing the management to fund the ongoing capex expansions in the US. Combined with the discounted valuations, healthy balance sheet, & FQ2'25 new bookings, we can understand why the stock has recorded rich recoveries since the April 2025 bottom.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited – TLX — Neutral
TLX GlobeNewsWire — August 13, 2025NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Telix Pharmaceuticals Limited (“Telix” or the “Company”) (NASDAQ: TLX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Novo Nordisk remains a buy despite share price weakness, as strong earnings and robust market share in diabetes and obesity care drive growth. The company's pipeline is rich, with late-stage R&D in obesity, cardiovascular, and rare diseases, including promising drugs like oral semaglutide and Mim8. Shareholder returns are supported by strong free cash flow, double-digit profit growth, and disciplined capital expenditures for future expansion.
Amazon Begins Adding Perishable Groceries to Same-Day Delivery in US — Positive
AMZN PYMNTS — August 13, 2025Amazon has begun adding perishable groceries to its Same-Day Delivery service in the United States.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Duolingo, Inc. - DUOL — Neutral
DUOL GlobeNewsWire — August 13, 2025NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Duolingo, Inc. (“Duolingo” or the “Company”) (NASDAQ: DUOL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Halliburton Elevates ESP Optimization With SK Well Pages — Positive
HAL Zacks Investment Research — August 13, 2025HAL's next-gen Summit Knowledge digital ecosystem boosts ESP performance with real-time insights, predictive tools and enhanced control.
NextDecade's Rio Grande LNG Project Secures Major Funding Boost — Positive
NEXT Zacks Investment Research — August 13, 2025NEXT secures $1.8B from TotalEnergies and GIP to advance the Train 4 expansion at its Rio Grande LNG facility in Texas.
Will PPL's Infrastructure Upgrades Boost Its Reliability & Earnings? — Positive
PPL Zacks Investment Research — August 13, 2025PPL is investing heavily in transmission and distribution upgrades to improve service reliability.
Annaly Shares Gains 10.3% in 1H25: Buy, Hold, or Take Profits? — Positive
NLY Zacks Investment Research — August 13, 2025Does NLY's high dividend yield, diversified mortgage portfolio and rising net interest income keep it attractive despite valuation concerns? Let us find out.
Broadcom (NASDAQ: AVGO) Stock Price Prediction and Forecast 2025-2030 (Aug 2025) — Negative
AVGO 24/7 Wall Street — August 13, 2025Regardless of this year's stock market volatility, the explosive demand for semiconductors and microchips that has grabbed news headlines and led the market higher over the past few years remains.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Molina Healthcare, Inc. - MOH — Neutral
MOH GlobeNewsWire — August 13, 2025NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
SMX Bridges the UN Plastics Treaty Divide with Verified Circularity (NASDAQ: SMX) — Neutral
SMX Accesswire — August 13, 2025NEW YORK, NY / ACCESS Newswire / August 13, 2025 / The United Nations (UN) plastics treaty talks, described as the most important environmental negotiations since the Paris Agreement, are straining under the weight of competing agendas. Over 100 countries and a coalition of scientists, non-governmental organizations (NGOs), and policymakers want aggressive measures: production caps, chemical phase-outs, and bans on harmful single-use plastics.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charter Communications, Inc. - CHTR — Neutral
CHTR GlobeNewsWire — August 13, 2025NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Charter Communications, Inc. (“Charter” or the “Company”) (NASDAQ: CHTR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charter Communications, Inc. - CHTR — Neutral
CHTR GlobeNewsWire — August 13, 2025NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Charter Communications, Inc. (“Charter” or the “Company”) (NASDAQ: CHTR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Rigetti Computing's Roadmap Is Strong, But The Stock Prices In The Bull Case — Positive
RGTI Seeking Alpha — August 13, 2025Rigetti Computing, Inc. is making strong technical progress, launching a 36-qubit system and targeting a 100+ qubit machine with high fidelity by year-end. RGTI stock's valuation is extremely high, with current prices assuming rapid revenue growth and margin improvement that are not yet visible in the business. The company remains heavily reliant on government funding, which is unpredictable and subject to political delays, impacting near-term revenue.
When 90% Isn't an A+: Elevance's Cost Crunch and Carelon's Cushion — Positive
ELV Zacks Investment Research — August 13, 2025ELV trims 2025 outlook as medical costs climb, but commercial growth and Carelon's momentum aim to steady performance.
Gold price could double in 5-10 years as investors become skeptical of fiat currencies - Thorsten Polleit — Positive
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL Kitco — August 13, 2025Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.